Purkiss Capital Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$482K Buy
3,751
+363
+11% +$42.5K 0.18% 101
2026
Q1
$408K Buy
3,388
+8
+0.2% +$924 0.18% 100
2025
Q4
$356K Sell
3,380
-327
-9% -$30.7K 0.17% 106
2025
Q3
$311K Sell
3,707
-919
-20% -$75.7K 0.15% 121
2025
Q2
$366K Buy
4,626
+1,944
+72% +$155K 0.2% 88
2025
Q1
$241K Buy
2,682
+288
+12% +$26.9K 0.18% 93
2024
Q4
$238K Buy
+2,394
New +$247K 0.21% 85

Other funds holding MRK

Purkiss Capital Advisors's MRK Position: Q2 2026 in Review

Purkiss Capital Advisors increased its Merck (MRK) stake by 11% in Q2 2026, buying an estimated $42.5K and bringing the position to 3,751 shares worth $482K. The position accounts for 0.18% of the portfolio, ranked #101.

Purkiss Capital Advisors first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. 1,752 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Purkiss Capital Advisors held 3,751 shares of Merck worth $482K as of Q2 2026.
  • Purkiss Capital Advisors bought 363 Merck shares in Q2 2026, an estimated $42.5K.
  • Merck made up 0.18% of Purkiss Capital Advisors's portfolio in Q2 2026, its #101 holding.
  • Purkiss Capital Advisors first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • 1,752 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Purkiss Capital Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.